NM_006397.3:c.635A>T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP3
The NM_006397.3(RNASEH2A):c.635A>T(p.Asn212Ile) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000775 in 1,613,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N212S) has been classified as Uncertain significance.
Frequency
Consequence
NM_006397.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006397.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RNASEH2A | NM_006397.3 | MANE Select | c.635A>T | p.Asn212Ile | missense splice_region | Exon 6 of 8 | NP_006388.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RNASEH2A | ENST00000221486.6 | TSL:1 MANE Select | c.635A>T | p.Asn212Ile | missense splice_region | Exon 6 of 8 | ENSP00000221486.4 | ||
| RNASEH2A | ENST00000593017.2 | TSL:2 | n.921A>T | splice_region non_coding_transcript_exon | Exon 4 of 6 | ||||
| THSD8 | ENST00000639767.2 | TSL:5 | n.*514A>T | splice_region non_coding_transcript_exon | Exon 7 of 9 | ENSP00000491410.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152170Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000219 AC: 55AN: 251418 AF XY: 0.000272 show subpopulations
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461414Hom.: 0 Cov.: 32 AF XY: 0.0000949 AC XY: 69AN XY: 727060 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 4 Pathogenic:1Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 212 of the RNASEH2A protein (p.Asn212Ile). This variant is present in population databases (rs377244188, gnomAD 0.08%). This missense change has been observed in individual(s) with Aicardi Goutieres syndrome (PMID: 23592335). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 66069). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on RNASEH2A function (PMID: 21454563, 31529068). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Uncertain:1
Variant summary: RNASEH2A c.635A>T (p.Asn212Ile) results in a non-conservative amino acid change located in the Ribonuclease HII/HIII domain (IPR024567) of the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00022 in 251418 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in RNASEH2A causing Aicardi Goutieres Syndrome (0.00022 vs 0.00025), allowing no conclusion about variant significance. c.635A>T has been reported in the literature in at least one compound heterozygous individual affected with Aicardi Goutieres Syndrome and heterozygous in affected individuals without a second variant identified (e.g. Rice_2013, Crow_2015). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function, indicating that the variant had no significant impact on catalytic activity, although it did cause a small reduction in substrate binding affinity (Coffin_2011, Nishimura_2019). The following publications have been ascertained in the context of this evaluation (PMID: 21454563, 25604658, 31529068, 23592335). ClinVar contains an entry for this variant (Variation ID: 66069). Based on the evidence outlined above, the variant was classified as uncertain significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at